Drugs & 
Pill 
Interaction 
Side 
Conditions 
Treatment 
Compare 
My Med 
Discount 
FDA 
Price 
Phonetic 
Health Drugs.com is the most popular, comprehensive and up-to-date source of drug information online. Providing free, peer-reviewed, accurate and independent data on more than 24,000 prescription drugs, over-the-counter medicines & natural products.
FDA Approves Imuldosa (ustekinumab-srlf), a Biosimilar to Stelara
(BUSINESS WIRE)-- October 11, 2024 Dong-A ST (President/CEO Jae-Hun Jung, KRX: 170900) announced on October 11 that Imuldosa™ (ustekinumab-srlf/DMB-3115),...
FDA Approves Hympavzi (marstacimab-hncq) for the Treatment of Adults and Adolescents with Hemophilia A or B Without Inhibitors
(BUSINESS WIRE) October 11, 2024 -- Pfizer Inc. (NYSE: PFE) announced today that the U.S. Food and Drug Administration (FDA) has approved Hympavzi (marstacimab-hncq)...
FDA Approves Itovebi (inavolisib) for the Combination Treatment of Advanced Hormone Receptor-Positive, HER2-Negative Breast Cancer With a PIK3CA Mutation
October 10, 2024 -- Genentech, a member of the Roche Group, announced today that the U.S. Food and Drug Administration (FDA) approved Itovebi (inavolisib),...
FDA Says Compounding Pharmacies Can Keep Making Weight-Loss Med Tirzepatide, for Now
Pharmacists may continue making compounded versions of the weight-loss medication tirzepatide while the U.S. Food and Drug Administration revisits its...
Your Sense of Smell May Be Quicker Than You Think
People sense millisecond shifts in odor as quickly as they might spot a change in color, new research shows.The study discounts the notion that smell is...
Parents or Ambulance: How a Child Reaches an ER Could Matter
It’s natural for a parent to bundle an injured child into a car and rush their kid to the emergency room.But that decision could actually delay their...
Certain Women May Need Mammograms Before Age 40 -- An Expert Explains Why
Women typically are urged to start receiving regular mammograms at age 40, but some might need to start even sooner, experts say.Specific risk factors...
GSK Announces Positive Phase III Results from ANCHOR Trials for Depemokimab in Chronic Rhinosinusitis with Nasal Polyps
GSK plc (LSE/NYSE: GSK) today announced positive headline results from the phase III clinical trials ANCHOR-1 and ANCHOR-2, which assessed the efficacy...
Data presented from the Phase 1b Clinical Trial Evaluating Low-Dose LTI-03 in Idiopathic Pulmonary Fibrosis
AUSTIN, Texas, Oct. 12, 2024 . Aileron Therapeutics, Inc. ("Aileron"), a biopharmaceutical company advancing a novel pipeline of first-in-class medicines...
Letter Nudges Increase Likelihood of Flu Vaccination for Adults With Chronic Diseases
For patients aged 18 to 64 years with chronic diseases, electronically delivered letter nudges increase influenza vaccination rates compared with usual...
Medical Financial Hardships Shared in Cancer-Linked Crowdfunding Stories
A considerable proportion of cancer-related crowdfunding stories share experiences of medical financial hardships and health-related social needs (HRSNs),...
Stealth BioTherapeutics Announces Positive Vote from FDA Advisory Committee Meeting Supporting Potential Approval of Elamipretide for the Treatment of Barth Syndrome
NEEDHAM, Mass., Oct. 11, 2024 /PRNewswire/ — Stealth BioTherapeutics Inc. (the “Company” or “Stealth”), a clinical-stage...
U.S. Scientists Awarded Nobel Prize in Medicine for Groundbreaking DNA Discovery
A pair of American scientists has been honored with the 2024 Nobel Prize in Medicine for their role in the groundbreaking discovery of microRNA—tiny...
Liberal Transfusion Strategy May Avert Unfavorable Neurological Outcome
For patients with acute brain injury, a liberal transfusion strategy is associated with a lower risk for having an unfavorable neurological outcome, according...
Here's Where Viruses Love to Lurk in Your Bathroom
The bad news first: shower heads and toothbrushes in an average bathroom are teeming with an extremely diverse collection of viruses, most of which have...
U.S. Food and Drug Administration (FDA) Accepts New Drug Application for Elinzanetant
Berlin, October 9, 2024 – Bayer today announced that the U.S. Food and Drug Administration (FDA) has accepted the company’s New Drug Application...
Recently Added
Recently added consumer and prescribing information: Imuldosa, Hympavzi, Flyrcado, Otulfi, Tecentriq Hybreza, Pavblu, Livdelzi, Yorvipath, Crexont, Lymphir
For Consumers
- Cerner Multum Drug Information
- Micromedex Advanced Consumer
- Natural Product Information for the Consumer
For Professionals
- FDA Professional Information
- Professional Patient Advice
- ASHP Monographs (AHFS DI)
- Micromedex Carenotes
- Natural Product Information
For Researchers
Latest FDA New Drug Approvals
- Imuldosa Imuldosa (ustekinumab-srlf) is a human interleukin-12 and -23 antagonist biosimilar to Stelara used for the treatment of plaque psoriasis...
- Hympavzi Hympavzi (marstacimab-hncq) is a tissue factor pathway inhibitor (TFPI) antagonist used for the treatment of adults and adolescents with...
- Itovebi Itovebi (inavolisib) is a phosphatidylinositol 3-kinase (PI3K) alpha inhibitor used for the combination treatment of PIK3CA-mutated...
Drugs in Development (Not yet approved)
- Yutrepia Yutrepia (treprostinil) is an inhaled dry powder formulation of treprostinil tentatively approved for the treatment of pulmonary arterial...
Drug Information
Tools
- Interaction Checker
- Pill Identifier
- Symptom Checker
- Medication Record
- Mobile Apps
- Drug Imprint Codes
- Community Support
- Compare Drugs
News & Alerts
- Medical News
- Clinical Trial Results
- FDA Drug Alerts
- FDA Consumer Updates
- New FDA Approvals
- New Drug Applications
- Drug Shortages
- Video Center
- Popular Articles
Professionals
Top 100 Drugs
- Abilify
- Acetaminophen
- Adderall
- Alprazolam
- Ambien
- Amitriptyline
- Amlodipine
- Amoxicillin
- Ativan
- Atorvastatin
- Avastin
- Azithromycin
- Baclofen
- Benadryl
- Benzonatate
- Biktarvy
- Botox
- Buprenorphine
- Bupropion
- Buspirone
- Cephalexin
- Cetirizine
- Ciprofloxacin
- Citalopram
- Clindamycin
- Clonazepam
- Clonidine
- Cyclobenzaprine
- Cymbalta
- Dexamethasone
- Diazepam
- Diclofenac
- Doxycycline
- Duloxetine
- Dupixent
- Eliquis
- Entyvio
- Epclusa
- Ezetimibe
- Famotidine
- Farxiga
- Fluoxetine
- Furosemide
- Gabapentin
- Humira
- Hydrochlorothiazide
- Hydrocodone
- Hydroxyzine
- Ibuprofen
- Januvia
- Jardiance
- Keytruda
- Klonopin
- Levothyroxine
- Lexapro
- Lisinopril
- Loratadine
- Lorazepam
- Losartan
- Lyrica
- Meloxicam
- Metformin
- Methadone
- Methylprednisolone
- Methocarbamol
- Methotrexate
- Metoprolol
- Metronidazole
- Miralax
- Mirtazapine
- Montelukast
- Mounjaro
- Mucinex
- Naloxone
- Naltrexone
- Naproxen
- Nitrofurantoin
- Omeprazole
- Opdivo
- Ondansetron
- Otezla
- Oxycodone
- Ozempic
- Pantoprazole
- Paxlovid
- Penicillin
- Percocet
- Phentermine
- Plan B
- Praluent
- Prednisone
- Promethazine
- Propranolol
- Prozac
- Qulipta
- Repatha
- Restasis
- Rexulti
- Semaglutide
- Seroquel
- Sertraline
- Sildenafil
- Skyrizi
- Soma
- Spironolactone
- Stelara
- Sublocade
- Suboxone
- Taltz
- Tamsulosin
- Tizanidine
- Toradol
- Tramadol
- Trazodone
- Trintellix
- Tylenol
- Ubrelvy
- Valium
- Venlafaxine
- Verzenio
- Viagra
- Vraylar
- Vyvanse
- Wegovy
- Wellbutrin
- Xanax
- Xolair
- Zepbound
- Zofran
- Zoloft
- Zyrtec
